Evidence map›Paper›PMID 40664639›Full record

ArticleCell death discovery2025

Fat-cartilage axis: the regulation of IL-6/Osteopontin signaling in osteoarthritis of mice.

Bing-Yang Dai, Zhong-Lian Huang, Ming-Gui Bao, Hong-Jiang Chen, Xiao-Hui Lu, Jun Hu

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bing-Yang DaiDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zhong-Lian HuangDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Ming-Gui BaoDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Hong-Jiang ChenDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Xiao-Hui LuDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jun HuDepartment of Orthopaedics, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. hjzkmst@126.com.ORCID http://orcid.org/0009-0008-8499-5928

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The infrapatellar fat pad (IPFP) acts as a bioactive reservoir, secreting proinflammatory cytokines that orchestrate both local and systemic inflammatory cascades. Despite its emerging role in knee osteoarthritis (OA) pathophysiology, the molecular and cellular mechanisms driving IPFP-mediated disease progression remain a critical gap in mechanistic understanding. 12-week-old male C57BL/6 mice underwent either destabilization of the medial meniscus (DMM) surgery or Sham surgery. Here, we find that the extreme sensitivity of IPFP makes it prone to act as a reservoir of inflammatory factors, which may indiscriminately disrupt the stability of its surrounding tissues. We further ascertain the role of IL-6 in initializing fibrosis in IPFP at early stage of OA and modulating osteopontin (OPN) secretion that cascades cartilage deterioration. Notably, removal of the IPFP in DMM mice reverses the abnormal functions of the knee joint. Compromising the progress of fibrosis by intra-IPFP injection of siRNA Cd61 or inhibition of OPN expression can drastically ameliorate cartilage deterioration. Our findings elucidate a pivotal role for IL-6 in instigating fibrotic remodeling within the IPFP during early-stage OA, concurrently regulating OPN secretion to propagate cartilage matrix degradation. This study thus establishes a conceptual framework for therapeutic intervention by targeting the IL-6/OPN signaling axis in the IPFP during OA initiation, offering a promising strategy to disrupt disease progression.

Identifiers

PMID40664639
PMCPMC12263885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.